Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Asset Writedowns and Impairment came in at $9.0 million in Q2 2026, up 28.57% quarter-over-quarter from $7.0 million in Q4 2025.
Analysis
Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Asset Writedowns and Impairment across 13 years of filings, most recently posting $9.0 million for Q2 2026.
- In Q2 2026, Asset Writedowns and Impairment changed N/A year-over-year to $9.0 million; the TTM figure through Jun 2026 stood at $17.0 million (down 26.09% YoY), while the FY2025 annual figure was $8.0 million, down 72.41% from the prior year.
- Asset Writedowns and Impairment came in at $9.0 million for Q2 2026 at Bausch Health Companies, up from $7.0 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $37.0 million in Q2 2023 to a low of $1.0 million in Q3 2022.
- Average Asset Writedowns and Impairment over 5 years is $9.6 million, with a median of $6.5 million recorded in 2022.
- Year-over-year, Asset Writedowns and Impairment plunged 94.59% in 2022 and soared 516.67% in 2023.
- Over 5 years, Asset Writedowns and Impairment stood at $1.0 million in 2022, then surged by 300.0% to $4.0 million in 2023, then jumped by 475.0% to $23.0 million in 2024, then sank by 69.57% to $7.0 million in 2025, then increased by 28.57% to $9.0 million in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $9.0 million in Q2 2026, $7.0 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Dec 31, 2024 | 23.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 37.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Mar 31, 2022 | 8.00 Mn |
| Dec 31, 2021 | 21.00 Mn |
| Sep 30, 2021 | 18.00 Mn |
| Jun 30, 2021 | 47.00 Mn |
| Mar 31, 2021 | 148.00 Mn |
| Dec 31, 2020 | 97.00 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Mar 31, 2020 | 14.00 Mn |